BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23692813)

  • 21. [Preventive surgical prcedures for inherited risk of breast cancer].
    Menke-Pluymers MB; Seynaeve C; van Geel AN; Klijn JG; Meijers-Heijboer EJ; Eggermont AM
    Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2663-7. PubMed ID: 16358615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].
    Vodermaier A; Bauerfeind I; Untch M; Nestle-Krämling C
    Psychother Psychosom Med Psychol; 2006; 56(9-10):351-61. PubMed ID: 16804803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
    Graeser MK; Engel C; Rhiem K; Gadzicki D; Bick U; Kast K; Froster UG; Schlehe B; Bechtold A; Arnold N; Preisler-Adams S; Nestle-Kraemling C; Zaino M; Loeffler M; Kiechle M; Meindl A; Varga D; Schmutzler RK
    J Clin Oncol; 2009 Dec; 27(35):5887-92. PubMed ID: 19858402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer risk in Jewish BRCA1 and BRCA2 mutation carriers: effects of oral contraceptive use and parental origin of mutation.
    Bernholtz S; Laitman Y; Kaufman B; Paluch Shimon S; Friedman E
    Breast Cancer Res Treat; 2011 Sep; 129(2):557-63. PubMed ID: 21499684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive surgery is associated with reduced cancer risk and mortality in women with BRCA1 and BRCA2 mutations.
    Domchek SM; Rebbeck TR
    LDI Issue Brief; 2010; 16(2):1-4. PubMed ID: 21545057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prophylactic mastectomy in women at high risk for breast cancer: indications and options].
    Scheufler O; Fritschen Uv
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):239-47. PubMed ID: 18716986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.
    Grann VR; Jacobson JS; Whang W; Hershman D; Heitjan DF; Antman KH; Neugut AI
    Cancer J Sci Am; 2000; 6(1):13-20. PubMed ID: 10696733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients.
    Ngoi N; Lee SC; Hartman M; Khin LW; Wong A
    Breast; 2013 Feb; 22(1):47-52. PubMed ID: 22560561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of BRCA1 and BRCA2 mutation carrier prediction models in breast and/or ovarian cancer families of French Canadian descent.
    Oros KK; Ghadirian P; Maugard CM; Perret C; Paredes Y; Mes-Masson AM; Foulkes WD; Provencher D; Tonin PN
    Clin Genet; 2006 Oct; 70(4):320-9. PubMed ID: 16965326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicians' experiences with BRCA1/2 testing in community settings.
    Keating NL; Stoeckert KA; Regan MM; DiGianni L; Garber JE
    J Clin Oncol; 2008 Dec; 26(35):5789-96. PubMed ID: 19001322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
    Fatouros M; Baltoyiannis G; Roukos DH
    Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].
    Arai M; Taki K; Iwase H; Takizawa K; Nishimura S; Iwase T
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):525-31. PubMed ID: 22504676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and preferred practice responsibilities.
    Nippert I; Julian-Reynier C; Harris H; Evans G; van Asperen CJ; Tibben A; Schmidtke J
    J Community Genet; 2014 Jan; 5(1):69-79. PubMed ID: 24297247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
    Jernström H; Lubinski J; Lynch HT; Ghadirian P; Neuhausen S; Isaacs C; Weber BL; Horsman D; Rosen B; Foulkes WD; Friedman E; Gershoni-Baruch R; Ainsworth P; Daly M; Garber J; Olsson H; Sun P; Narod SA
    J Natl Cancer Inst; 2004 Jul; 96(14):1094-8. PubMed ID: 15265971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys.
    Eisinger F; Stoppa-Lyonnet D; Lasset C; Vennin P; Chabal F; Noguès C; Moatti JP; Sobol H; Julian-Reynier C
    Fam Cancer; 2001; 1(3-4):157-62. PubMed ID: 14574172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Men's knowledge and attitude towards breast cancer in Saudi Arabia. A cross-sectional study.
    Al-Amoudi SM; Abduljabbar HS
    Saudi Med J; 2012 May; 33(5):547-50. PubMed ID: 22588817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H; van Geel B; van Putten WL; Henzen-Logmans SC; Seynaeve C; Menke-Pluymers MB; Bartels CC; Verhoog LC; van den Ouweland AM; Niermeijer MF; Brekelmans CT; Klijn JG
    N Engl J Med; 2001 Jul; 345(3):159-64. PubMed ID: 11463009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy.
    Metcalfe KA; Esplen MJ; Goel V; Narod SA
    Psychooncology; 2004 Jan; 13(1):14-25. PubMed ID: 14745742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage.
    Kurian AW; Hartman AR; Mills MA; Ford JM; Daniel BL; Plevritis SK
    Health Expect; 2005 Sep; 8(3):221-33. PubMed ID: 16098152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
    Schrag D; Kuntz KM; Garber JE; Weeks JC
    N Engl J Med; 1997 May; 336(20):1465-71. PubMed ID: 9148160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.